HomeTPST • NASDAQ
add
Tempest Therapeutics Inc
Previous close
$1.64
Day range
$1.59 - $1.68
Year range
$1.50 - $12.23
Market cap
23.24M USD
Avg Volume
168.80K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.08M | -70.71% |
Net income | -4.02M | 70.89% |
Net profit margin | — | — |
Earnings per share | -0.62 | 84.62% |
EBITDA | -4.01M | 71.07% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 7.71M | -74.54% |
Total assets | 16.93M | -59.19% |
Total liabilities | 10.26M | -54.11% |
Total equity | 6.67M | — |
Shares outstanding | 14.34M | — |
Price to book | 1.21 | — |
Return on assets | -59.85% | — |
Return on capital | -68.96% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -4.02M | 70.89% |
Cash from operations | -3.57M | 64.78% |
Cash from investing | — | — |
Cash from financing | 3.77M | -79.02% |
Net change in cash | 193.00K | -97.53% |
Free cash flow | -5.25M | -7.42% |
About
Founded
2011
Headquarters
Website
Employees
4
